dievini Hopp BioTech holding GmbH & Co KG 13D and 13G filings for CureVac N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-24 4:31 pm Sale |
2023-02-23 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 83,880,935 37.800% |
-664,772 (-0.79%) |
Filing |
| 2022-11-14 4:02 pm Sale |
2022-11-08 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 84,545,707 45.200% |
-1,614,683 (-1.87%) |
Filing |
| 2022-05-05 4:01 pm Sale |
2022-05-04 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,160,390 46.000% |
-158,700 (-0.18%) |
Filing |
| 2022-03-17 5:10 pm Purchase |
2022-03-17 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,319,090 46.200% |
396,349 (+0.46%) |
Filing |
| 2022-02-22 06:26 am Sale |
2022-02-22 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 85,922,741 46.000% |
-158,700 (-0.18%) |
Filing |
| 2022-01-13 4:14 pm Purchase |
2022-01-13 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,081,441 46.000% |
11,667 (+0.01%) |
Filing |
| 2021-10-15 1:21 pm Sale |
2021-10-11 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 86,069,774 46.100% |
-1,449,193 (-1.66%) |
Filing |
| 2020-08-24 10:44 am Purchase |
2020-10-14 | 13D | CureVac N.V. CVAC |
dievini Hopp BioTech holding GmbH & Co KG | 87,518,967 49.200% |
87,518,967 (New Position) |
Filing |